These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15285012)
21. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis. Nosho K; Yoshida M; Yamamoto H; Taniguchi H; Adachi Y; Mikami M; Hinoda Y; Imai K Carcinogenesis; 2005 May; 26(5):892-9. PubMed ID: 15695237 [TBL] [Abstract][Full Text] [Related]
22. [Inhibition of angiogenesis in pancreatic carcinoma by cyclooxygenase-2 antisense oligodeoxynucleotides]. Wang XP; Xie CG; Dong YW; Zhang RL; Wu LY; Wu K Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1501-4. PubMed ID: 14521730 [TBL] [Abstract][Full Text] [Related]
24. Association between Cyclooxygenase expression and colorectal adenoma characteristics. Einspahr JG; Krouse RS; Yochim JM; Danenberg PV; Danenberg KD; Bhattacharyya AK; Martínez ME; Alberts DS Cancer Res; 2003 Jul; 63(14):3891-3. PubMed ID: 12873979 [TBL] [Abstract][Full Text] [Related]
25. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis. Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. Shi H; Xu JM; Hu NZ; Xie HJ World J Gastroenterol; 2003 Jul; 9(7):1421-6. PubMed ID: 12854133 [TBL] [Abstract][Full Text] [Related]
27. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Murono S; Inoue H; Tanabe T; Joab I; Yoshizaki T; Furukawa M; Pagano JS Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6905-10. PubMed ID: 11381123 [TBL] [Abstract][Full Text] [Related]
28. Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy. Uchida K; Schneider S; Yochim JM; Kuramochi H; Hayashi K; Takasaki K; Yang D; Danenberg KD; Danenberg PV Clin Cancer Res; 2005 May; 11(9):3363-8. PubMed ID: 15867236 [TBL] [Abstract][Full Text] [Related]
29. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer]. Buecher B; Heymann MF; Blottière HM Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047 [No Abstract] [Full Text] [Related]
30. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates. Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060 [TBL] [Abstract][Full Text] [Related]
31. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082 [TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic significance of cyclooxygenase-2 mRNA expression in human breast carcinoma]. Pang D; Zhao X; Xue Y Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):567-9. PubMed ID: 12667327 [TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753 [TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Gupta RA; Tejada LV; Tong BJ; Das SK; Morrow JD; Dey SK; DuBois RN Cancer Res; 2003 Mar; 63(5):906-11. PubMed ID: 12615701 [TBL] [Abstract][Full Text] [Related]
35. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
36. Tanshinone II--a inhibits angiogenesis through down regulation of COX-2 in human colorectal cancer. Zhou LH; Hu Q; Sui H; Ci SJ; Wang Y; Liu X; Liu NN; Yin PH; Qin JM; Li Q Asian Pac J Cancer Prev; 2012; 13(9):4453-8. PubMed ID: 23167360 [TBL] [Abstract][Full Text] [Related]
37. Rofecoxib inhibits retinal neovascularization via down regulation of cyclooxygenase-2 and vascular endothelial growth factor expression. Liu NN; Sun YZ; Zhao N; Chen L Clin Exp Ophthalmol; 2015 Jul; 43(5):458-65. PubMed ID: 25472856 [TBL] [Abstract][Full Text] [Related]